For more than a year, economists and market-watchers have been wondering out loud whether commercial real estate is the “next shoe to drop” in the country’s ongoing economic crisis. Last month, a Congressional Oversight Panel made the …

Continued here:
Is commercial real estate the next shoe to drop? (The Daily Record …

Second Rooftop in Southern California Edison’s Massive Solar Panel Installation Program Now Generating Power in Chino ROSEMEAD, Calif.–( BUSINESS WIRE )–The roof of a 458,000-square-foot industrial building in Chino, Calif. is now providing as much as one million watts of solar power to Southern California’s Inland Empire. This is the second installation in Southern California Edison’s (SCE’s) plan to place advanced solar panels on hundreds of otherwise unused comm

View post:
Second Rooftop in Southern California Edison’s Massive Solar Panel Installation Program Now Generating Power in Chino

Some friends of mine are conducting the following law and charity related seminars. The 1st seminar is on October 22, the 2nd on November 6. INVESTING IN COMMERCIAL & MULTI-USE PROPERTY – A UNIQUE OPPORTUNITY TO ASK REAL ESTATE INVESTMENT QUESTIONS OF AN EXPERIENCED PANEL FEATURING THREE ATTORNEYS AND A CPA Topics will include : •Assessment & Real Estate Taxes •Foreclosure & Short Sales •Best Legal Entity for Investing •Income Tax Issues Panel : •Richard A. Crane – Law

Read the original:
A Couple of New Seminars & Charity Fundraisers From Friends of Mine

Live-PR.com (Pressemitteilung) Panel questions loan relief plan Boston Globe The program, the report states, was not designed to deal with foreclosures caused by unemployment. Foreclosures , the report said, are now stalking families … Bank of America Ups Its Foreclosure Prevention Efforts CNBC Treasury Trumpets Milestones In Foreclosure -Prevention Effort EasyBourse.com Treasury Trumpets Milestones In Foreclosure Prevention Effort NASDAQ Minnea

More:
Panel questions loan relief plan – Boston Globe

GlaxoSmithKline ( GSK ) received positive news yesterday when the US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) voted unanimously in favor of the company’s experimental kidney cancer drug, Votrient (pazopanib). Importantly, the panel voted that Votrient can benefit patients by slowing the disease, despite some risk of liver damage. We believe the company may be asked to submit data from ongoing studies to ensure that liver toxicity associated with the use o

Read more:
FDA Panel Backs Glaxo’s Votrient – Analyst Blog

Ray, over at VSE Restoration, provides the subtitles:Once the White House embraces a direction for U.S. human spaceflight, Stanley said NASA should then be allowed to conduct a thorough architecture study to include apples-to-apples comparisons of the cost, safety and risk of the Augustine panel’s options, as well as alternative scenarios the panel might not have considered.May I use my cynical filter to translate?Once the White House embraces one of the Augustine committee options, NASA human s

Link:
Translating Doug Stanley